Independent Director · Heron Therapeutics, Inc. (HRTX)

Chair, Audit Committee

Craig Johnson — Heron Therapeutics Director Compensation (2025)

Fiscal year 2025 director compensation for Craig Johnson at Heron Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 30, 2026 (DEF 14A). Open the filing on EDGAR.

What they were paid

Heron Therapeutics Director Compensation Table · the one fiscal year held
In US dollars, as Heron Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$77,500$43,629$30,515$0$151,644

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Heron Therapeutics, Inc. DEF 14A filed April 30, 2026, accession 0001193125-26-196306, and prior-year filings. Open the filing on EDGAR.

Committees

FY2025 · as the proxy prints them

Audit (Chair) · Compensation

The rest of the Heron Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Adam MorganChair of the Board$159,700
Christian WaageIndependent Director$144,144
Craig CollardDirector$0
Michael KasetaIndependent Director$135,469
Sharmila DissanaikeIndependent Director—
Tom CusackIndependent Director$229,104

The full Heron Therapeutics compensation record

free company brief

This page is one director within Heron Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy